Piperacillin and tazobactam exhibit linear pharmacokinetics after multiple standard clinical doses

Antimicrobial Agents and Chemotherapy

Volumn 43, Issue 6, 1999, Pages 1465-1468

  Auclair, Barbara ^a,c   Ducharme, Murray P ^a,b  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b MDS Inc   (Canada)

^c NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PIPERACILLIN; TAZOBACTAM;

ANTIMICROBIAL THERAPY; ARTICLE; COMPARTMENT MODEL; DRUG BLOOD LEVEL; DRUG URINE LEVEL; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; NORMAL HUMAN; PRIORITY JOURNAL;

EID: 0033036208     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.43.6.1465     Document Type: Article

References (30)

1. Akaike, H. 1992. A Bayesian extension of the minimum AIC procedure of autoregressive model fitting. Biometrika 66:237-242.
2. Aronoff, G. R., R. S. Sloan, M. E. Brier, and F. C. Luft. 1983. The effect of piperacillin dose on elimination kinetics in renal impairment. Eur. J. Clin. Pharmacol. 24:543-547.
3. Batra, V. K., J. A. Morrison, K. C. Lasseter, and V. A. Joy. 1979. Piperacillin kinetics. Clin. Pharmacol. Ther. 26:41-53.
4. Bergan, T., and J. D. Williams. 1982. Dose dependence of piperacillin pharmacokinetics. Chemotherapy 28:153-159.
5. Collins, D., and A. Forrest 1995. IT2S user's guide. State University of New York at Buffalo, Buffalo, N.Y.
6. D'Argenio, D. Z., and A. Schumitzky. 1992. ADAPT-II user's guide. Biomedical Simulation Resources, University of Southern California, Los Angeles, Calif.
7. Evans, M. A. L., T. Leung, P. Wilson, and J. D. Williams. 1979 Pharmacokinetics of intravenously administered antibiotics: a study of piperacillin, a new semi-synthetic penicillin. Drugs Exp. Clin. Res. 5:111-116.
8. Evans, M. A. L., P. Wilson, T. Leung, and J. D. Williams. 1978, Pharmacokinetics of piperacillin following intravenous administration. J. Antimicrob. Chemother. 4:255-261.
9. Gibaldi, M., and D. Perrier. 1982. Pharmacokinetics, 2nd ed. Marcel Dekker, New York, N.Y.
10. Johnson, C. A., C. E. Halstenson, J. S. Kelloway, B. E. Shapiro, S. W. Zimmennan, A. Tonelli, R. Faulkner, A. Dutta, J. Haynes, D. S. Greene, and O. Kuye. 1992. Single-dose pharmacokinetics of piperacillin and tazobactam in patients with renal disease. Clin. Pharmacol. Ther. 51:32-41.
11. Jung, D., and N. K. Mahajan. 1984. An improved micro-scale liquid-chromatographic assay for piperacillin in plasma and urine. Clin. Chem. 30:12-24.
12. Jusko, W. J. 1989. Pharmacokinetics of capacity-limited systems. J. Clin. Pharmacol. 29:488-493.
13. Kinzig, M., F. Sorgel, B. Brismar, and C. E. Nord. 1992. Pharmacokinetics and tissue penetration of tazobactam and piperacillin in patients undergoing colorectal surgery. Antimicrob. Agents Chemother. 36:1997-2004.
14. Ludden, T. M. 1991. Nonlinear pharmacokinetics: clinical implications. Clin. Pharmacokinet. 20:429-446.
15. Morrison, J. A., and V. K. Batra. 1979. Pharmacokinetics of piperacillin sodium in man. Drugs Exp. Clin. Res. 5:105-110.
16. Ocampo, A. P., K. D. Hoyt, N. Wadgaonkar, A. H. Carver, and C. V. Puglisi. 1989. Determination of tazobactam and piperacillin in human plasma, serum, bile and urine by gradient elution reversed-phase high-performance liquid chromatography. J. Chromatogr. 496:167-179.
17. Occhipinti, D. J., S. Pendland, L. L. Schoonover, E. B. Rypins, L. H. Danzinger, and K. A. Rodvold. 1997. Pharmacokinetics and pharmacodynamics of two multiple-dose piperacillin-tazobactam regimens. Antimicrob. Agents Chemother. 41:2511-2517.
18. Reed, M. D., J. Goldfarb, T. S. Yamashita, E. Lemon, and J. L. Blumer. 1994. Single-dose pharmacokinetics of piperacillin and tazobactam in infants and children. Antimicrob. Agents Chemother. 38:2817-2826.
19. Schoonover, L. L., D. J. Occhipinti, K. A. Rodvold, and L. H. Danziger. 1995. Piperacillin/tazobactam: a new β-lactam/β-lactamase inhibitor combination. Ann. Pharmacother. 29:501-514.
20. Sorgel, F., and M. Kinzig. 1993. The chemistry, pharmacokinetics and tissue distribution of piperacillin/tazobactam. J. Antimicrob. Chemother. 31(Suppl. A):39-60.
21. Sorgel, F., and M. Kinzig. 1994. Pharmacokinetics and tissue penetration of piperacillin/tazobactam with particular reference to its potential in abdominal and soft tissue infections. Eur. J. Surg. 573(Suppl.):39-44.
22. Sullivan, M. C., C. H. Nightingale, R. Quintiliani, and K. Sweeney. 1993. Comparison of the pharmacokinetic and pharmacodynamic activity of piperacillin and mezlocillin. Pharmacotherapy 13:607-612.
23. Tartaglione, T. A., L. Nye, N. Vishniavsky, W. Poynor, and R. Polk. 1986. Multiple-dose pharmacokinetics of piperacillin and azlocillin in 12 healthy volunteers. Clin. Pharm. 5:911-916.
24. Tjandramaga, T. B., A. Mullie, R. Verbesselt, P. J. De Schepper, and L. Verbist 1978. Piperacillin: human pharmacokinetics after intravenous and intramuscular administration. 14:829-837.
25. Van Ginneken, C. A. M., and F. G. M. Russel. 1989. Saturable pharmacokinetics in the renal excretion of drugs. Clin. Pharmacokinet. 16:38-54.
26. Wagner, J. G. 1993. Pharmacokinetics for the pharmaceutical scientist. Technomic Publishing Co., Lancaster, Pa.
27. Walmsley, S., and the Committee on Antimicrobial Agents. 1997. Piperacillin/tazobactam. Can. J. Infect. Dis. 8:79-84.
28. Welling, P. G., W. A. Craig, R. W. Bundtzen, F. W. Kwok, A. U. Gerber, and P. Madsen. 1983. Pharmacokinetics of piperacillin in subjects with various degrees of renal function. Antimicrob. Agents Chemother. 23:881-887.
29. Wise, R., M. Logan, M. Cooper, and J. M. Andrews. 1991. Pharmacokinetics and tissue penetration of tazobactam administered alone and with piperacillin. Antimicrob. Agents Chemother. 35:1081-1084.
30. Zaghloul, I., N. Kuck, and A. Yacobi. 1997. The effect of tazobactam on the pharmacokinetics and the antibacterial activity of piperacillin in dogs. Int. J. Pharm. 153:115-121.